Literature DB >> 18469066

Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels.

Tina E Brinkley1, Noriaki Kume, Hirokazu Mitsuoka, Michael D Brown, Dana A Phares, Robert E Ferrell, Toru Kita, James M Hagberg.   

Abstract

The lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) expressed on vascular cells plays a major role in atherogenesis by internalizing and degrading oxidized low-density lipoprotein. LOX-1 can be cleaved from the cell surface and released as soluble LOX-1 (sLOX-1), and elevated sLOX-1 levels may be indicative of atherosclerotic plaque instability. We examined associations between the LOX-1 gene 3'UTR-C/T and G501C polymorphisms and plasma sLOX-1 levels in 97 healthy older men and women. The frequencies for the 3'UTR-T and 501C alleles were 46 and 10%, respectively. Plasma sLOX-1 levels were significantly higher in the 3'UTR CC genotype group compared with both the CT (P=0.02) and TT genotype groups (P=0.002). Plasma sLOX-1 levels were also significantly higher in the 501GC genotype group compared with the GG genotype group (P=0.004). In univariate analyses, sLOX-1 levels were significantly associated with both the 3'UTR-C/T and G501C polymorphisms. These associations remained significant after adjusting for age, sex, race and body mass index. In conclusion, variation in the LOX-1 gene is associated with plasma sLOX-1 levels in older men and women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469066      PMCID: PMC2652129          DOI: 10.1113/expphysiol.2008.042267

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  25 in total

1.  Identification of soluble forms of lectin-like oxidized LDL receptor-1.

Authors:  T Murase; N Kume; H Kataoka; M Minami; T Sawamura; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

2.  Faster enzymatic procedure for serum triglycerides.

Authors:  E J Sampson; L M Demers; A F Krieg
Journal:  Clin Chem       Date:  1975-12       Impact factor: 8.327

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

Review 6.  Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis.

Authors:  N Kume; T Kita
Journal:  Curr Opin Lipidol       Date:  2001-08       Impact factor: 4.776

Review 7.  LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.

Authors:  Mingyi Chen; Tomoh Masaki; Tatsuya Sawamura
Journal:  Pharmacol Ther       Date:  2002-07       Impact factor: 12.310

8.  Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction.

Authors:  Mariko Tatsuguchi; Michiko Furutani; Jun-ichi Hinagata; Takeshi Tanaka; Yoshiyuki Furutani; Shin-ichiro Imamura; Masatoshi Kawana; Tomoh Masaki; Hiroshi Kasanuki; Tatsuya Sawamura; Rumiko Matsuoka
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

9.  Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction.

Authors:  R Mango; F Clementi; P Borgiani; G B Forleo; M Federici; G Contino; E Giardina; L Garza; I E Fahdi; R Lauro; J L Mehta; G Novelli; F Romeo
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

10.  Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Y Craig; Sue E LaPierre; Erin Luedecking Zimmer; Dennis M McNamara; Daniel F Pauly; Barry Sharaf; Richard Holubkov; C Noel Bairey Merz; George Sopko; Franklin Bontempo; M Ilyas Kamboh
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

View more
  14 in total

1.  The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions.

Authors:  Amie K Lund; JoAnn Lucero; Melissa Harman; Michael C Madden; Jacob D McDonald; Jean Clare Seagrave; Matthew J Campen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea.

Authors:  Chun-Yan Xu; Da-Ju Li; Chun-Ling Wu; Han-Jian Lou; Hong-Wei Jiang; Guo-Qiang Ding
Journal:  Genet Test Mol Biomarkers       Date:  2015-03-31

3.  3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients.

Authors:  Angela Sciacqua; Ivan Presta; Maria Perticone; Eliezer J Tassone; Francesco Andreozzi; Maria Chiara Quitadamo; Federica Carla Sangiuolo; Giorgio Sesti; Francesco Perticone
Journal:  Intern Emerg Med       Date:  2012-09-29       Impact factor: 3.397

4.  The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients.

Authors:  Ozlem Kurnaz; A Başak Akadam-Teker; Hülya Yilmaz-Aydoğan; Atike Tekeli; Turgay Isbir
Journal:  Mol Biol Rep       Date:  2011-09-07       Impact factor: 2.316

5.  Magnesium Sulfate Improves Some Risk Factors for Atherosclerosis in Patients Suffering from One or Two Coronary Artery Diseases: A Double-blind Clinical Trial Study.

Authors:  Ali Reza Sobhani; Hossein Farshidi; Fariba Azarkish; Mahdiya Eslami; Ebrahim Eftekhar; Mansoor Keshavarz; Nepton Soltani
Journal:  Clin Pharmacol       Date:  2020-09-25

Review 6.  LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.

Authors:  Suowen Xu; Sayoko Ogura; Jiawei Chen; Peter J Little; Joel Moss; Peiqing Liu
Journal:  Cell Mol Life Sci       Date:  2012-11-03       Impact factor: 9.261

7.  The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis.

Authors:  Anthony Au; Lyn R Griffiths; Kian-Kai Cheng; Cheah Wee Kooi; Looi Irene; Loo Keat Wei
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

8.  Role of sLOX-1 in intracranial artery stenosis and in predicting long-term prognosis of acute ischemic stroke.

Authors:  Xian-Mei Li; Ping-Ping Jin; Jie Xue; Jie Chen; Qin-Fen Chen; Xiao-Qian Luan; Zeng-Rui Zhang; Tie-Er Yu; Zheng-Yi Cai; Kai Zhao; Bei Shao
Journal:  Brain Behav       Date:  2017-12-13       Impact factor: 2.708

9.  Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population.

Authors:  Xin Guo; Yuanyuan Xiang; Heng Yang; Lijin Yu; Xiangdong Peng; Ren Guo
Journal:  J Atheroscler Thromb       Date:  2016-11-12       Impact factor: 4.928

Review 10.  Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.

Authors:  Szilvia Fiatal; Róza Ádány
Journal:  Front Public Health       Date:  2018-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.